While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

Multiple myeloma is a rare cancer that originates in white blood cells (plasma cells) that produce antibodies.

Alfie Swain was diagnosed with multiple myeloma — a type of blood cancer — in August 2020, after discovering a tumour on his ...

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal ...